CLINICAL_TRIALS
trial_result
· 2009-03-03
Clinical Trial Update: Subconjunctival Bevacizumab Effect on Bleb Vascularity [Phase 2]
Summary
Phase 2 clinical trial evaluating subconjunctival bevacizumab to impact bleb vascularity and fibrosis after trabeculectomy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rabin Medical Center | Conditions: Bleb Vascularity, Bleb Fibrosis | Phase 2 | Status: UNKNOWN